Mottolese M - Search Results

1

99Tcm-MIBI scintimammography in 300 consecutive patients: factors that may affect accuracy.

Tofani A, Sciuto R, Semprebene A, Festa A, Pasqualoni R, Giunta S, Mottolese M, Benevolo M, Botti C, Maini CL. Tofani A, et al. Among authors: mottolese m. Nucl Med Commun. 1999 Dec;20(12):1113-21. doi: 10.1097/00006231-199912000-00003. Nucl Med Commun. 1999. PMID: 10664992

2

Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.

Sciuto R, Pasqualoni R, Bergomi S, Petrilli G, Vici P, Belli F, Botti C, Mottolese M, Maini CL. Sciuto R, et al. Among authors: mottolese m. J Nucl Med. 2002 Jun;43(6):745-51. J Nucl Med. 2002. PMID: 12050317 Free article. Clinical Trial.

3

Somatostatin receptor imaging in CNS tumours using 111In-octreotide.

Maini CL, Sciuto R, Tofani A, Ferraironi A, Carapella CM, Occhipinti E, Mottolese M, Crecco M. Maini CL, et al. Among authors: mottolese m. Nucl Med Commun. 1995 Sep;16(9):756-66. doi: 10.1097/00006231-199509000-00006. Nucl Med Commun. 1995. PMID: 7478408

4

In-111 octreotide scintigraphy in the diagnostic evaluation of en plaque meningioma. A case report.

Maini CL, Tofani A, Cioffi RP, Sciuto R, Morace E, Crecco M, Mottolese M. Maini CL, et al. Among authors: mottolese m. Clin Nucl Med. 1995 Jun;20(6):508-11. doi: 10.1097/00003072-199506000-00008. Clin Nucl Med. 1995. PMID: 7648733

5

Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.

Maini CL, Tofani A, Sciuto R, Semprebene A, Cavaliere R, Mottolese M, Benevolo M, Ferranti F, Grandinetti ML, Vici P, Lopez M, Botti C. Maini CL, et al. Among authors: mottolese m. J Nucl Med. 1997 Oct;38(10):1546-51. J Nucl Med. 1997. PMID: 9379190 Free article.

6

111In-octreotide scintigraphy in pituitary adenomas.

Tofani A, Cucchi R, Pompili A, Carapella C, Crecco M, Mottolese M, Maini CL. Tofani A, et al. Among authors: mottolese m. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):94-7. Q J Nucl Med. 1995. PMID: 9002760

7

Clinical relevance of 111In-octreotide scans in CNS tumors.

Sciuto R, Ferraironi A, Semprebene A, Occhipinti E, Mastrostefano R, Crecco M, Mottolese M, Maini CL. Sciuto R, et al. Among authors: mottolese m. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):101-3. Q J Nucl Med. 1995. PMID: 9002762

8

Contribution of fluorescence in situ hybridization to immunohistochemistry for the evaluation of HER-2 in breast cancer.

Cianciulli AM, Botti C, Coletta AM, Buglioni S, Marzano R, Benevolo M, Cione A, Mottolese M. Cianciulli AM, et al. Among authors: mottolese m. Cancer Genet Cytogenet. 2002 Feb;133(1):66-71. doi: 10.1016/s0165-4608(01)00559-3. Cancer Genet Cytogenet. 2002. PMID: 11890992

9

Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes.

Buglioni S, Di Filippo F, Terrenato I, Casini B, Gallo E, Marandino F, Maini CL, Pasqualoni R, Botti C, Di Filippo S, Pescarmona E, Mottolese M. Buglioni S, et al. Among authors: mottolese m. PLoS One. 2013;8(3):e58823. doi: 10.1371/journal.pone.0058823. Epub 2013 Mar 22. PLoS One. 2013. PMID: 23533593 Free PMC article.

10

Low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen-A2-positive breast cancer patients.

Nisticò P, Mottolese M, Mammi C, Benevolo M, Del Bello D, Rubiu O, Gentile FP, Botti C, Venturo I, Natali PG. Nisticò P, et al. Among authors: mottolese m. J Natl Cancer Inst. 1997 Feb 19;89(4):319-21. doi: 10.1093/jnci/89.4.319. J Natl Cancer Inst. 1997. PMID: 9048837 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters